The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a foundation that works to improve population health and health equity.
Quarterly Topic
Quarterly Article
December 2024 Federica Zavattaro, Viktor von Wyl, Felix Gille,
Public trust is critical to both system legitimacy and the successful implementation of data-driven health initiatives. Legislations are an essential instrument for building public trust, as they can have a dual effect on trust: a passive effect by reinforcing the public perception of an active regulatory system that upholds the rule of law and an active effect as a tool for policymakers to signal trust-building actions to be undertaken during the implementation phase. More
September 2024 Iselin Dahlen Syversen, Kevin Schulman, Aaron S. Kesselheim, William B. Feldman,
The Medicare drug negotiation framework established under the Inflation Reduction Act is far more limited than other frameworks in seven health systems explored in this study. More
September 2023 Monica Aggarwal, Brian Hutchison, Reham Abdelhalim, G. Ross Baker,
Context: Despite significant investments to transform primary care, Canada lags behind its peers in providing timely access to regular doctors or… More
March 2022 Sahil Sandhu, Hugh Alderwick, Laura M. Gottlieb,
This Perspective describes how public-financing approaches have progressed in the United States and England to support social prescribing. More
March 2022 Lindor Qunaj, Anna Kaltenboeck, Peter B. Bach,
This study by Lindor Qunaj of Montefiore Medical Center and colleagues finds that compulsory licensing, a practice whereby national authorities can enable the production of a generic before the original patent expires, is rarely used to address drug prices and, when used, is unlikely to contribute to price discounts. More
March 2021 Veronique C. Raimond, William B. Feldman, Benjamin N. Rome, Aaron S. Kesselheim,
Context: Prescription drug spending per capita in the United States is higher than in most other industrialized countries. Policymakers seeking to… More
February 2020 Tsung-Mei Cheng,
In a Perspective, Tsung-Mei Cheng of Princeton pays tribute to her late husband by bringing attention to an often-overlooked path to universal health coverage that he strongly supported: Germany’s all-payer system. More